Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic Cardiomyopathy.

Susanne Trost1, Martin LeWinter

  • 1Division of Cardiology, University of Vermont College of Medicine, Fletcher Allen Health Care, 111 Colchester Avenue, Burlington, VT 05401, USA. MartinLeWinter@vtmed.org

Current Treatment Options in Cardiovascular Medicine
|November 7, 2001
PubMed
Summary

Diabetic cardiomyopathy significantly increases congestive heart failure (CHF) risk, even without other factors. Aggressive management of blood pressure, lipids, and glucose, alongside lifestyle changes, is crucial for diabetic patients with heart conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

'Ablate and pace' reduces mortality in heart failure patients with atrial fibrillation: an updated meta-analysis.

European heart journal open·2026
Same author

Pericardial Diseases: International Position Statement on New Concepts and Advances in Multimodality Cardiac Imaging.

JACC. Cardiovascular imaging·2024
Same author

Pericardial late gadolinium enhancement and time to recurrence: a substudy from RHAPSODY, a phase 3 clinical trial of rilonacept in recurrent pericarditis.

European heart journal. Imaging methods and practice·2024
Same author

Absence of Pericarditis Recurrence in Rilonacept-Treated Patients With COVID-19 and SARS-CoV-2 Vaccination: Results From the RHAPSODY Long-term Extension.

CJC open·2024
Same author

Left Ventricular Gene Expression in Heart Failure With Preserved Ejection Fraction-Profibrotic and Proinflammatory Pathways and Genes.

Circulation. Heart failure·2023
Same author

The interplay between bone and heart health as reflected in medication effects: A narrative review.

Women's health (London, England)·2023

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Background:

  • Diabetes mellitus is a primary risk factor for congestive heart failure (CHF).
  • Diabetic cardiomyopathy is a distinct entity increasing CHF risk, especially with hypertension or coronary artery disease.
  • Diabetic cardiomyopathy can cause CHF independently of other risk factors.

Purpose of the Study:

  • To outline the critical management strategies for diabetic patients at risk of or with congestive heart failure.
  • To emphasize the importance of controlling comorbid conditions like hypertension and dyslipidemia.

Main Methods:

  • Review of existing literature and clinical guidelines on managing diabetes and heart failure.
  • Discussion of pharmacologic treatments including ACE inhibitors, beta-blockers, and diabetes medications.

Related Experiment Videos

  • Emphasis on lifestyle modifications such as diet, exercise, and smoking cessation.

    • Main Results:

    • Aggressive blood pressure control (<130/85 mm Hg) is vital, with ACE inhibitors as first-line therapy.
    • Stringent dyslipidemia treatment and blood glucose control (HbA1c <7%) are essential.
    • Specific therapies are indicated for dilated cardiomyopathy (low ejection fraction) and diastolic dysfunction.

    Conclusions:

    • Integrated management of diabetes, hypertension, dyslipidemia, and heart failure is paramount.
    • Lifestyle interventions are fundamental components of care for diabetic patients with cardiac conditions.
    • Treatment strategies should be tailored to the specific cardiac dysfunction present.